SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-19-007847
Filing Date
2019-04-24
Accepted
2019-04-24 16:00:21
Documents
5
Period of Report
2019-04-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20190423_8k.htm 8-K 60312
2 EXHIBIT 3.1 ex_141491.htm EX-3.1 11812
3 EXHIBIT 10.1 ex_141492.htm EX-10.1 151377
4 EXHIBIT 10.2 ex_141493.htm EX-10.2 94307
5 EXHIBIT 10.3 ex_141494.htm EX-10.3 67222
  Complete submission text file 0001437749-19-007847.txt   386731
Mailing Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 19763851
SIC: 2836 Biological Products, (No Diagnostic Substances)